Epidemiology of Hepatitis B, C and Delta in Reunion Island
NCT ID: NCT03362866
Last Updated: 2018-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2019-01-31
2023-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France
NCT07038863
Molecular Epidemiology of Hepatitis B in Cayenne General Hospital, French Guiana
NCT04886102
"Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection
NCT01732081
Establishment of Retrospective and Prospective Multicenter Cohort for Chronic Hepatitis B
NCT02263755
Testing and Epidemiology of Delta Hepatitis
NCT05181956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with confirmed HBsAg and / or anti HCV positive Ab
* residing in Reunion Island
* followed in one of the participating centers
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de la Réunion
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/CHU/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.